Inflammatory Skin Conditions Flashcards
1
Q
What is Eczema?
A
- Eczema (or dermatitis) is a chronic skin condition common in children but also prevalent in adults.
- 20% prevalence in <12 years old in the UK
2
Q
What are the causes of Atopic Eczema?
A
Not fully understood, but
- Positive family history of atopy (i.e. eczema, asthma, allergic rhinitis) is often present
- Primary genetic defect in skin barrier function (loss of function variants of the protein filaggrin) appears to underlie atopic eczema
- Exacerbating factors such as infections, allergens (e.g. chemicals, food, dust, pet fur), sweating, heat, occupation and severe stress
3
Q
What is the presentation of Atopic Eczema?
A
- Acute presentation consists of itchy papules and vesicle often weepy (exudative)
- Chronic lesions: dry scaly itchy patches can be erythematous in paler skin or grey/ brown in richly pigmented skin
- More common on the face and extensor aspects of limbs in infants, and the flexor aspects in children and adults
- In richly pigmented skin eczema may present as brown, grey or purple bumps (papular eczema or follicular eczema)
- Chronic scratching/rubbing leads to lichenification
- Across of skin types eczema can lead to pigmentary changes such as hypopigmentation (reduced pigmentation) and hyperpigmentation (increased pigmentation)
- Nail may show pitting and ridging of the nails
4
Q
What is the management of Atopic Eczema?
A
- General measures: avoid known exacerbating agents, frequent emollients +/- bandages and bath oil/soap substitute
- Topical therapies: topical steroids for active areas; topical immunomodulators (e.g. tacrolimus, pimecrolimus) for maintenance therapy as steroid-sparing agents
- Oral therapies: antihistamines for symptomatic relief, antibiotics (e.g. flucloxacillin) for secondary bacterial infections, and antivirals (e.g. aciclovir) for secondary herpes infection
- Phototherapy and immunosuppressants (e.g. azathioprine, ciclosporin, methotrexate) for severe non-responsive cases, biologic therapy
5
Q
What are complications of Atopic Eczema?
A
- Secondary bacterial infection (crusted weepy lesions)
- Secondary viral infection - molluscum contagiosum (pearly papules with central umbilication), viral warts and eczema herpeticum
6
Q
What is Acne?
A
- An inflammatory disease of the pilosebaceous follicle
- Over 80% of teenagers aged 13- 18 years
7
Q
What are the causes of Acne Vulgaris?
A
- Hormonal (androgen)
- Contributing factors include
- Increased sebum production
- Abnormal follicular keratinization
- Bacterial colonization (Propionibacterium acnes)
- Inflammation
8
Q
What is the presentation of Acne Vulgaris?
A
- Non-inflammatory lesions (mild acne): open and closed comedones (blackheads and whiteheads)
- Inflammatory lesions (moderate and severe acne): papules, pustules, nodules, and cysts
-
In richly pigmented skin:
- Inflammatory lesions’ may not be so apparent, instead hyperpigmented lesions (‘acne hyperpigmented macules’) are seen.
- Hyperpigmented lesions may also signify ongoing inflammation
- Non-erythematous nodules may be present and detected by palpation
Commonly affects the face, chest and upper back
9
Q
What is the management of Acne Vulgaris?
A
- General measures: no specific food has been identified to cause acne, treatment needs to be continued for at least 6 weeks to produce effect
- Topical therapies (for mild acne): benzoyl peroxide and topical antibiotics (antimicrobial properties), and topical retinoids (comedolytic and anti-inflammatory properties)
- Oral therapies (for moderate to severe acne) - oral antibiotics, and anti-androgens (in females)
- Oral retinoids (for severe acne)
10
Q
What are complications of Acne Vulgaris?
A
- Post-inflammatory hyperpigmentation
- Scarring
- Deformity
- Psychological and social effects
11
Q
What is Psoriasis?
A
A chronic inflammatory skin disease due to hyperproliferation of keratinocytes and inflammatory cell infiltration
12
Q
What are types of Psoriasis?
A
- Chronic plaque psoriasis (most common type)
- Guttate (raindrop lesions)
- Seborrhoeic (naso-labial and retro-auricular)
- Flexural (body folds)
- Pustular (palmar-plantar)
- Erythrodermic (total body redness)
13
Q
What is the cause of Psoriasis?
A
- Complex interaction between genetic, immunological and environmental factors
- Precipitating factors include trauma (which may produce a Köebner phenomenon), infection (e.g. tonsillitis), drugs, stress, and alcohol
14
Q
How does Psoriasis present?
A
- Well-demarcated erythematous scaly plaques
- In richly pigmented skin psoriasis can present as dark brown, grey or purple patches or plaques
- Lesions can sometimes be itchy, burning or painful
- Common on the extensor surfaces of the body and over scalp
- Auspitz sign (scratch and gentle removal of scales cause capillary
- bleeding)
- 50% have associated nail changes (e.g. pitting, onycholysis)
- 5-8% suffer from associated psoriatic arthropathy - symmetrical polyarthritis, asymmetrical oligomonoarthritis, lone distal interphalangeal disease, psoriatic spondylosis, and arthritis mutilans (flexion deformity of distal interphalangeal joints)
15
Q
What is the management of Psoriasis?
A
- General measures: avoid known precipitating factors, emollients to reduce scales
- Topical therapies (for localised and mild psoriasis): vitamin D analogues, topical corticosteroids, coal tar preparations, dithranol, topical retinoids, keratolytics and scalp preparations
- Phototherapy (for extensive disease): phototherapy i.e. UVB and photochemotherapy i.e. psoralen+UVA
- Oral therapies (for extensive and severe psoriasis, or psoriasis with systemic involvement): methotrexate, retinoids, ciclosporin, mycophenolate mofetil, fumaric acid esters,and biological agents (e.g. etanercept, adalimumab, ustekinumab)